A recent report in Nature describes how the Trump administration is weakening peer review in favor of ideology-based grant ...

Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, and Eledon Pharmaceuticals, Inc.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The Omnipod 6 automated insulin delivery algorithm met ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

Multi-organ system and quality-of-life benefits sustained through five years of treatment– 82% response rate for the multi-component endpoint – ...

The improved readout speed also enables 4K 120 fps video recording for the first time on Sony's 1/2-type sensor. This reduces ...

Gilead and Merck report positive phase III results for once-weekly HIV regimen islatravir/lenacapavir, while ending a lung cancer study.

BMS presented trial results from mezigdomide and arlocabtagene autoleucel at EHA 2026. Credit: Tada Images/Shutterstock.com. Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline ...

This hospital deputy superintendent from Taiwan shares the key changes required to build a truly data-aware, proactive ...

A Chicago man says his dream wedding bankroll turned into a nightmare betting binge, and he is blaming DraftKings in federal ...

If the juggernaut of SIR rolls on unchecked through Phase 3, it risks transforming the Indian electorate from a ...

Sony Semiconductor Solutions Corporation (Sony) has announced the upcoming release of the LYTIA 610, a 1/2-type stacked CMOS ...